Similar articles

• Are the best antiretrovirals being used in Africa?

  John L, Kambugu A, Songa PM, Castelnuovo B, Colebunders R, Kamya M. John L, et al. J HIV Ther. 2006 Mar;11(1):11-5. J HIV Ther. 2006. PMID: 16706250 Review. No abstract available.
• Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.

  Breton G, Lewden C, Spire B, Salmon D, Brun-Vézinet F, Duong M, Allavena C, Leport C, Salamon R; APROCO COPILOTE ANRS CO8 Study Group. Breton G, et al. HIV Med. 2007 Apr;8(3):164-70. doi: 10.1111/j.1468-1293.2007.00447.x. HIV Med. 2007. PMID: 17461860 Clinical Trial.
• [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

  Panel de expertos de Gesida y Plan Nacional sobre el Sida. Panel de expertos de Gesida y Plan Nacional sobre el Sida. Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Enferm Infecc Microbiol Clin. 2009. PMID: 19246124 Spanish.
• AIDS, HIV, antiretrovirals and Africa.

  Gazzard B. Gazzard B. J HIV Ther. 2006 Mar;11(1):4-6. J HIV Ther. 2006. PMID: 16706248 No abstract available.
• In for the long haul: debate paves way for long-term trials.

  Bass E. Bass E. Res Initiat Treat Action. 2001 Spring;7(1):5-7. Res Initiat Treat Action. 2001. PMID: 11548386 No abstract available.